Skip to main content

Want a detailed portfolio tracker?

Synlogic (SYBX) P/E (2017 - 2026)

Synlogic (SYBX) P/E from Oct 2, 2017 to Jul 21, 2026. The TTM Synlogic (SYBX) P/E is -12.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Synlogic (SYBX)

YearP/EChange
2026-12.89-1.65%
2025-13.10+1781.60%
2024-0.70+137.13%
2023-0.29-64.45%
2022-0.83-62.84%
2021-2.22-1.34%
2020-2.25-73.79%
2019-8.60-63.20%
2018-23.36-74.82%
2017-92.78N/A

Comparison Synlogic (SYBX) P/E with competitors

Synlogic (SYBX) P/E is -12.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.58%
FGENFibroGen Inc0.24-101.86%
CHRSCoherus Biosciences Inc0.85-106.58%
FBIOFortress Biotech Inc0.95-107.36%
ORMPOramed Pharmaceuticals Inc1.50-111.66%
AGENAgenus Inc3.01-123.35%
INVAInnoviva Inc3.15-124.47%
VXRTVaxart Inc3.55-127.54%
CRMDCorMedix Inc3.63-128.15%
CVACCureVac N.V.4.45-134.50%
GLPGGalapagos NV4.86-137.70%
SRPTSarepta Therapeutics Inc4.88-137.88%
ABEOAbeona Therapeutics Inc5.39-141.80%
ABUSArbutus Biopharma Corp5.60-143.42%
ZVRAZevra Therapeutics Inc5.89-145.68%
SPROSpero Therapeutics Inc6.23-148.33%
CGENCompugen Ltd6.31-148.99%
RIGLRigel Pharmaceuticals6.87-153.32%
SLXNSilexion Therapeutics Corp7.30-156.61%
OMEROmeros Corporation9.26-171.84%
AUPHAurinia Pharmaceuticals Inc9.58-174.37%
PLXProtalix BioTherapeutics Inc10.89-184.51%
ACADAcadia Pharmaceuticals Inc11.73-191.01%
TBPHTheravance Biopharma Inc12.26-195.15%
ADMAAdma Biologics Inc12.42-196.36%
HRMYHarmony Biosciences Holdings Inc13.82-207.24%
SABSSAB Biotherapeutics Inc14.14-209.69%
NAGENiagen Bioscience Inc14.82-214.98%
INCYIncyte Corp15.82-222.77%
REGNRegeneron Pharmaceuticals Inc15.86-223.04%
PBYIPuma Biotechnology Inc17.32-234.36%
CPRXCatalyst Pharmaceuticals Inc17.44-235.32%
EXELExelixis Inc17.54-236.09%
TGTXTG Therapeutics Inc18.97-247.17%
MDXGMimedx Group Inc20.55-259.48%
XOMAXOMA Royalty Corp22.87-277.50%
ARGXArgen X SE24.30-288.54%
CTMXCytomX Therapeutics Inc24.82-292.60%
XOMAOXOMA Royalty Corp25.34-296.67%
HALOHalozyme Therapeutics Inc25.62-298.83%
XOMAPXOMA Royalty Corp25.67-299.19%
VRTXVertex Pharmaceuticals Inc27.99-317.23%
RPRXRoyalty Pharma plc - Class A28.69-322.60%
SLNOSoleno Therapeutics Inc29.02-325.15%
ASNDAscendis Pharma A/S30.09-333.45%
LGNDLigand Pharmaceuticals Inc - Class B37.91-394.18%
APLSApellis Pharmaceuticals Inc39.02-402.79%
BMRNBiomarin Pharmaceutical Inc42.21-427.55%
KRYSKrystal Biotech Inc45.34-451.85%
ONCBeiGene Ltd69.54-639.61%
PHARPharming Group N.V.75.03-682.17%
TECHBio-Techne Corp101.96-891.16%
VCELVericel Corp109.92-952.95%
ALNYAlnylam Pharmaceuticals Inc117.96-1015.37%
GMABGenmab140.29-1188.61%
TLXTelix Pharmaceuticals Ltd162.15-1358.25%
CORTCorcept Therapeutics Inc212.86-1751.70%